Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | METAP1 | P53582 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28981357 | 0.96 | LMNA (0.46) | LMNASMPD1MEN1CYP1A2KMT2A | |
| SCHEMBL28101537 | 0.89 | LMNA (0.44) | LMNASMPD1MEN1CYP1A2KMT2A | |
| SCHEMBL2518475 | 0.86 | LMNA (0.50) | LMNASMPD1MEN1CYP1A2KMT2A | |
| SCHEMBL28767714 | 0.84 | LPAR3 (0.38) | LMNASMPD1MEN1CYP1A2KMT2A | |
| Phosphoric Acid SCHEMBL368038 | 0.82 | LMNA (0.67) | LMNAMEN1CYP1A2KMT2AFDPS | |
| SCHEMBL2046370 | 0.82 | SMPD1 (0.42) | SMPD1FDPSMETAP1PTPN1LPAR1 | |
| SCHEMBL11591189 | 0.80 | LMNA (0.44) | LMNAMEN1CYP1A2KMT2AFDPS | |
| SCHEMBL2045703 | 0.80 | LMNA (0.55) | LMNAMEN1CYP1A2KMT2ATHRB | |
| Itaconate SCHEMBL9419185 | 0.80 | ALOX15 (0.40) | LMNA | |
| SCHEMBL10447789 | 0.79 | SMPD1 (0.39) | SMPD1FDPSMETAP1PTPN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024259923-A1 | INTERPENETRATING NETWORK TYPE PVDC EMULSION AND PREPARATION METHOD THEREFOR | 浙江衢州巨塑化工有限公司 | 2024-12-26 | — | — | WO | claimed |
| EP-4034094-B1 | PHOSPHODIESTERASE INHIBITORS AND USE | ZENSHINE PHARMACEUTICALS NANJING GROUP CO LTD (CN) | 2026-04-15 | — | — | EP | disclosed |
| US-20260091148-A1 | DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS | Higuchi, Takahiro (DE) | 2026-04-02 | — | — | US | disclosed |
| US-12590084-B2 | Oxadiazole HDAC6 inhibitors and uses thereof | EIKONIZO THERAPEUTICS, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-20260078119-A1 | DEGRADER COMPOUNDS AND USES THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260055090-A1 | OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF | EIKONIZO THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | US | disclosed |
| EP-4698530-A1 | NK3 MODULATORS AND USES THEREOF | Kallyope, Inc. (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12544448-B2 | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors | Revolution Medicines, Inc. (US) | 2026-02-10 | — | — | US | disclosed |
| US-20260035361-A1 | COMPOUNDS FOR MODULATING HUR (ELAVL1) | SHANGHAI DEGRON BIOMEDICAL TECH CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
| US-20260015350-A1 | AZAQUINAZOLINE PAN-KRAS INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | disclosed |
| EP-2337805-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010043392-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2010-04-22 | — | — | WO | disclosed |
| US-7585907-B2 | Inorganic powder-containing resin composition, a film-forming material layer, a transfer sheet, method of producing a substrate having a dielectric layer formed thereon, and a substrate having a dielectric layer formed thereon | NITTO DENKO CORPORATION (JP) | 2009-09-08 | — | — | US | disclosed |
| US-20060199883-A1 | Inorganic powder-containing resin composition, film-forming material layer, transfer sheet, method for producing substrate with dielectric layer, and substrate with dielectric layer | NITTO DENKO CORPORATION (JP) | 2006-09-07 | — | — | US | disclosed |
| EP-1666526-A1 | INORGANIC POWDER-CONTAINING RESIN COMPOSITION, FILM-FORMING MATERIAL LAYER, TRANSFER SHEET, METHOD FOR PRODUCING SUBSTRATE WITH DIELECTRIC LAYER, AND SUBSTRATE WITH DIELECTRIC LAYER | NITTO DENKO CORPORATION (JP) | 2006-06-07 | — | — | EP | disclosed |
| US-20050142413-A1 | Separator for fuel cell, method for producing the same, and fuel cell using the same | SANSHO KAKOU CO., LTD. (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-0537426-B1 | A germicidal and fungicidal agent and a germicidal and fungicidal method | NICCA CHEMICAL CO (JP) | 1995-12-27 | — | — | EP | disclosed |
| US-5362910-A | Germicidal and fungicidal agent and a germicidal and fungicidal method | NICCA CHEMICAL CO., LTD. (JP) | 1994-11-08 | — | — | US | disclosed |
| EP-0537426-A1 | A germicidal and fungicidal agent and a germicidal and fungicidal method | NICCA CHEMICAL CO., LTD. (JP) | 1993-04-21 | — | — | EP | disclosed |
| US-4297468-A | CONTAINING UNITS DERIVED FROM AN UNSATURATED CARBOXYLIC ACID, AND ONE OTHER UNSATURATED COMPOUND | CHEMISCHE FABRIK STOCKHAUSEN & CIE (DE) | 1981-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078119-A1 | DEGRADER COMPOUNDS AND USES THEREOF | CTTN, SRC, PTK2 | LMNA 2215/4885SMPD1 4523/4885MEN1 2994/4885 |
| US-12590084-B2 | Oxadiazole HDAC6 inhibitors and uses thereof | HDAC6, HDAC1, HDAC9 | LMNA 3231/4885SMPD1 3846/4885MEN1 4699/4885 |
| US-20260055090-A1 | OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF | HDAC6, HDAC1, CTTN | LMNA 4412/4885SMPD1 4724/4885MEN1 3173/4885 |
| US-20260091148-A1 | DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS | TNNC1, TNNT2, TNNI3 | LMNA 400/4885SMPD1 409/4885MEN1 965/4885 |
| US-20260015350-A1 | AZAQUINAZOLINE PAN-KRAS INHIBITORS | KRAS, NRAS, HRAS | LMNA 2151/4885SMPD1 2842/4885MEN1 304/4885 |
| US-20260035361-A1 | COMPOUNDS FOR MODULATING HUR (ELAVL1) | ELAVL1, ELAVL3, HNRNPL | LMNA 1137/4885SMPD1 3044/4885MEN1 1990/4885 |
| US-12544448-B2 | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors | RICTOR, MTOR, MLST8 | LMNA 2304/4885SMPD1 2200/4885MEN1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.